<DOC>
	<DOCNO>NCT02298556</DOCNO>
	<brief_summary>To describe effectiveness angiotensin-converting enzyme inhibitor non-dihydropyridine calcium channel blocker single pill combination systolic blood pressure ( SBP ) lower hypertensive patient elevated heart rate type 2 diabetes</brief_summary>
	<brief_title>An Observational Study Describe Effectiveness Angiotensin Converting Enzyme Inhibitor Calcium Channel Blocker Combination Management Hypertensive Patients With Elevated Heart Rate Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Male female ≥ 18 year old Has already diagnose hypertension Has already diagnose type 2 diabetes mellitus Started use angiotensinconverting enzyme inhibitor nondihydropyridine calcium channel blocker single pill combination within maximum 1 week enrolment Heart rate ≥70 beat per minute Pregnant breast feed female Current need use antihypertensive drug ( ) addition angiotensinconverting enzyme inhibitor nondihydropyridine calcium channel blocker single pill combination Having contraindication angiotensinconverting enzyme inhibitor nondihydropyridine calcium channel blocker ; Has treat antihypertensive treatment ( ) angiotensinconverting enzyme inhibitor nondihydropyridine calcium channel blocker single pill combination Is currently participate another clinical nonclinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>ACE Inhibitors</keyword>
	<keyword>Calcium Channel Blockers</keyword>
</DOC>